@immunomix.com
Immunomic Therapeutics is a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
Immunomic Therapeutics is a pioneering clinical stage biotechnology company that specializes in the development of vaccines. They utilize their proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE®), to create vaccines that generate broad immune responses by leveraging the body's natural biochemistry. The company's primary focus is on applying the UNITE® platform to oncology, where it has the potential for various applications, including biologic antigen-derived antibodies.
Immunomic Therapeutics has built a pipeline of programs in oncology, animal health, infectious disease, and allergy. Their investigational UNITE® platform works by engineering chimeric proteins that direct antigen presenting cells to present antigens to the immune system through a targeted pathway, resulting in a robust immune response. Immunomic Therapeutics aims to transform lives through pioneering vaccines.
Their vision is to have regulatory approved products in pollen allergy, food allergy, cancer, and animal health by 2025. They are currently involved in various clinical trials and have partnerships with other organizations. With their innovative approach and commitment to improving healthcare, Immunomic Therapeutics is at the forefront of vaccine development
Company Type
Privately Held
Company Size
11-50
Year Founded
2005
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online